Therapeutic strategies using monoclonal antibodies in autoimmune disease.
Pankewycz
O
O
Charles A. Dana Research Institute, Boston, Massachusetts.
Strom
T B
TB
Kelley
V E
VE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte; D001327:Autoimmune Diseases / Q000628:therapy*; D001685:Biological Factors; D015704:CD4 Antigens; D016827:CD8 Antigens; D016207:Cytokines; D000949:Histocompatibility Antigens Class II; D006801:Humans; D007136:Immunoglobulins; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D001685:Biological Factors; D015704:CD4 Antigens; D016827:CD8 Antigens; D016207:Cytokines; D000949:Histocompatibility Antigens Class II; D007136:Immunoglobulins